MDCT-Based Radiomics Features for the Differentiation of Serous Borderline Ovarian Tumors and Serous Malignant Ovarian Tumors

MLA

Yu X, et al. “MDCT-Based Radiomics Features for the Differentiation of Serous Borderline Ovarian Tumors and Serous Malignant Ovarian Tumors.” Cancer Management and Research, vol. ume 13, Jan. 2021, pp. 329–36. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.323e706809a049f3811cab41e9b8d382&authtype=sso&custid=ns315887.

APA

Yu X, Wang L, Yu H, Zou Y, Wang C, Jiao J, Hong H, & Zhang S. (2021). MDCT-Based Radiomics Features for the Differentiation of Serous Borderline Ovarian Tumors and Serous Malignant Ovarian Tumors. Cancer Management and Research, ume 13, 329–336.

Chicago

Yu X, Wang L, Yu H, Zou Y, Wang C, Jiao J, Hong H, and Zhang S. 2021. “MDCT-Based Radiomics Features for the Differentiation of Serous Borderline Ovarian Tumors and Serous Malignant Ovarian Tumors.” Cancer Management and Research ume 13 (January): 329–36. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.323e706809a049f3811cab41e9b8d382&authtype=sso&custid=ns315887.